Furthermore, the role of promoter variants in clinical malaria (e.g., rs1800629) is highlighted by reports associating TNF with vulnerability to severe disease, including cerebral malaria (97–102) and malaria in pregnancy (103, 104) (Figure 3 and Supplementary Table 1). The gene discussed is TNF; the disease is malaria.